Zen Research PLC
25 October 2000
Letter to Company Announcements Office
Pursuant to Chapter 10 of the Listing Rules, Zen Research Plc ('Zen') submits
the announcement below with regard to a 'Class 2 Transaction'. As noted in the
announcement, Zen Research (Ireland) Ltd., a subsidiary of Zen, has entered into
a licence agreement with Calimetrics, Inc., a U.S. corporation to acquire
rewrite technology for use in CD and DVD products. The total consideration of
this transaction is US$5,000,000. This transaction has a percentage ratio that
is 5% or more but is less than 25% under the Gross Asset Test set forth in
Section 10.5(a) of the Listing Rules.
Letter from Zen Research Plc
ANNOUNCEMENT
ZEN RESEARCH ENTERS INTO LICENCE AGREEMENT WITH
CALIMETRICS TO ACQUIRE RIGHTS FOR USE WITH MULTIPLE TRACK
READING TECHNOLOGY FOR CD AND DVD DRIVE SYSTEMS
Zen Research plc ('Zen') today announced that its subsidiary, Zen Research
(Ireland) Ltd. has entered into a licensing agreement with Calimetrics, Inc., a
U.S. Corporation ('Calimetrics'). Calimetrics has developed proprietary
technology for writing data to reflective optical media such as CD-R, CD-RW,
DVD-R and rewritable DVD. Pursuant to the licence agreement, Zen has acquired
rights for use with multiple track reading technology for CD and DVD drive
systems.
Calimetrics is a technology company engaged in the business of designing and
developing proprietary technology for writing optical data storage media.
Zen shall pay Calimetrics US$5,000,000 as a licence fee, to be paid in
instalments linked to Calimetrics' achievement of certain benchmarks. The
consideration will be paid in cash from the proceeds of Zen's recent listing on
the London Stock Exchange.
Zen believes that this rewrite technology will complement its core technologies
and supplement Zen's entry into the rewritable optical disc drive market.
Zen designs, develops and licenses technology and intellectual property for use
in the production of high performance components for CD and DVD optical storage
devices. For company information, visit Zen at http://www.zenresearch.com
Contact:
David Aber (UK): + 44 7740 308014
(Israel): + 972 3 671 5238
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.